MedTrace Logo

VIRTUUS Children's Study

NCT03719339 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 445

Last updated 2025-12-12

No results posted yet for this study

Summary

The objective of the VIRTUUS Children's Study is to adapt identified and validated adult noninvasive diagnostic and prognostic biomarkers for the characterization of allograft status in pediatric recipients of kidney allografts.

Conditions

  • Renal Transplant Rejection
  • Pediatric Kidney Disease
  • End Stage Renal Disease
  • Nephropathy
  • BK Virus (Nephropathy)
  • Antibody-mediated Rejection
  • Acute Cellular Graft Rejection

Sponsors & Collaborators

Principal Investigators

  • Brendan Keating, DPhil · Children's Hospital of Philadelphia and Hospital of The University of Pennsylvania

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-10
Primary Completion
2024-05-31
Completion
2026-03-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03719339 on ClinicalTrials.gov